Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
Watson gets FDA nod for generic Lysteda
Watson Pharmaceuticals received FDA approval for its tranexamic acid tablets to treat heavy menstrual bleeding. The therapy is a generic of Lysteda from Ferring Pharmaceuticals.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .